Will elevated serum hemoglobin levels in newly arrived fetal cows affect mesenchymal stem cells?

In this situation, I would contact the supplier's technical support directly, send them the COA, cell photos, and the vacuolation observed after passaging, and request a batch replacement or return. A tight lead time is not a reason to push through; if the cells have already shown vacuolation, continuing to use them may further worsen the cell condition, and subsequent experimental data will also be unreliable. You can ask the supplier whether they have warehouse stock available for transfer or whether they can provide low-hemoglobin serum from another source under the same brand for emergency use. At the same time, check whether the laboratory has frozen reserves or borrow a low-hemoglobin batch from a nearby laboratory as a transition. Waiting two weeks for a new batch is too long; it is advisable to prioritize securing a replacement.

Hemoglobin at 45 mg/dL is indeed significantly higher than the previous level of below 20, typically indicating more pronounced hemolysis. Vacuolization of mesenchymal stem cells after passaging is most likely caused by a change in serum lot, but could also be due to the culture environment, passaging procedure, or mycoplasma interference. It is recommended to first perform centrifugation: take 10 mL of serum and centrifuge at 1000-1500 g for 10 minutes to check for red blood cell fragment pellets; at the same time, use the old lot of serum for a parallel passaging control. If vacuolization occurs only with the 45 mg/dL lot, it is recommended not to continue using it for critical cells, and to contact the supplier for a low-hemoglobin replacement lot of the same brand or a return.

Elevated hemoglobin is usually associated with hemolysis, but it does not necessarily cause vacuolation on its own; free hemoglobin oxidation products, lipid peroxides, and complement components may also be involved. If you still want to salvage this batch of serum, you can try small-scale testing: culture with low-concentration serum (e.g., 5%-8%), or mix it 1:1 with the old batch and observe whether vacuolation is reduced; however, this is not a routine practice, and mesenchymal stem cells are sensitive to serum changes, so it is not recommended for formal experiments. The safer option is to return the product and switch to a new batch, while keeping the remaining old batch as a control. If the supplier accepts a return for this batch, remember to retain 20-30 mL of sample for subsequent complaint comparison.